A new study published in Cancer Cell reveals that blocking a key nutrient-scavenging process in pancreatic tumors reprograms the tumor microenvironment—reducing fibrosis, enhancing T cell infiltration ...

Antibody-drug conjugates and bispecific antibodies are reshaping the future of targeted therapy in oncology and immunology.

In this exclusive interview, Dr. Raza Bokhari, CEO of Medicus Pharma, introduces SkinJect patch—a cellulose-based microneedle ...